YU42395A - 2,4-disulfonyl phenyl butyl nitrone, its salts and their use as pharmaceuticals - Google Patents

2,4-disulfonyl phenyl butyl nitrone, its salts and their use as pharmaceuticals

Info

Publication number
YU42395A
YU42395A YU42395A YU42395A YU42395A YU 42395 A YU42395 A YU 42395A YU 42395 A YU42395 A YU 42395A YU 42395 A YU42395 A YU 42395A YU 42395 A YU42395 A YU 42395A
Authority
YU
Yugoslavia
Prior art keywords
salts
pharmaceutically acceptable
pharmaceuticals
disulfonyl
phenyl butyl
Prior art date
Application number
YU42395A
Other languages
Serbo-Croatian (sh)
Other versions
YU49496B (en
Inventor
John M. Carney
Original Assignee
Oklahoma Medical Research Foundation
University Of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation, University Of Kentucky Research Foundation filed Critical Oklahoma Medical Research Foundation
Priority to YU42395A priority Critical patent/YU49496B/en
Publication of YU42395A publication Critical patent/YU42395A/en
Publication of YU49496B publication Critical patent/YU49496B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Opisani su 2,3-disulfonil tercijarni butil nitron i njegove farmaceutski prihvatljive soli. Soli mogu sadržati farmaceutski prihvatljiv jednovalentni anjon. Farmaceutski preparat koji sadrži 2,3-disulfonil alfafenil tercijarni butil nitron i njegove farmaceutski prihvatljive soli zajedno sa farmaceutski prihvatljivim nosačem za parenteralne injekcije ili farmaceutski prihvatljivom nosaču za oralno davanje.2,3-Disulfonyl tertiary butyl nitron and its pharmaceutically acceptable salts are described. The salts may contain a pharmaceutically acceptable monovalent anion. A pharmaceutical composition comprising 2,3-disulfonyl alfaphenyl tertiary butyl nitron and its pharmaceutically acceptable salts together with a pharmaceutically acceptable carrier for parenteral injection or a pharmaceutically acceptable carrier for oral administration.

YU42395A 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals YU49496B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Publications (2)

Publication Number Publication Date
YU42395A true YU42395A (en) 1998-08-14
YU49496B YU49496B (en) 2006-08-17

Family

ID=47598467

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42395A YU49496B (en) 1995-06-21 1995-06-21 2,4-disulfophenyl butyl nitrone, its salts, and their use as pharmaceuticals

Country Status (1)

Country Link
YU (1) YU49496B (en)

Also Published As

Publication number Publication date
YU49496B (en) 2006-08-17

Similar Documents

Publication Publication Date Title
SG64903A1 (en) 2,4-disulfonyl phenyl butyl nitrone its salts and their uses as pharmaceuticals
CA2239174A1 (en) Novel compounds with analgesic effect
NO960373L (en) Stabilized pharmaceutical preparation containing bupropion
BR9611175B1 (en) pharmaceutical compounds and compositions.
IT235830Y1 (en) "LUER-LOCK FITTING WITH PROTECTION CAP FOR MEDICATION LINES-INFUSION-TRANSFUSION."
IL131651A0 (en) A pharmaceutical formulation containing benzimidazoles with amino acid/caclodextrin combinations and a process for producing the same
BR9607862A (en) Film-forming pharmaceutical composition for transdermal administration
FR2677984B1 (en) N-SUBSTITUTED IMIDAZOLINE DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
CA2268967A1 (en) Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
ITRM910922A0 (en) ANTIPHALALGIC PHARMACEUTICAL COMPOSITION FOR ENDONASAL ADMINISTRATION, PROCEDURE FOR PREPARING IT AND METHOD FOR APPLYING IT.
DE69425429T2 (en) PROPYLENE BLOCK COPOLYMER, METHOD FOR THE PRODUCTION THEREOF AND MODIFIED COPOLYMER MADE THEREOF
NO976074D0 (en) Two- and three-value small molecule inhibitors for selectin
MX9800408A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing said salts.
IT1301968B1 (en) ERYTHROMYCIN DERIVATIVES FOR ANTIBIOTIC ACTIVITY
ES2062137T3 (en) USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.
WO1997009317A3 (en) Optically active phenyl pyrimidine derivative as analgesic agent
BR9305161A (en) Compound, pharmaceutical composition and process for preparing the compound
GEP20032914B (en) Derivatives of 1,3,4-Oxadiazolone
SE9504662D0 (en) New compounds
YU42395A (en) 2,4-disulfonyl phenyl butyl nitrone, its salts and their use as pharmaceuticals
CZ20022240A3 (en) Mannich bases of substituted 1-a 2-naphthol
ATE219665T1 (en) DOSAGE FORMS AND USES THEREOF
DE59510583D1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE
ZA954297B (en) 2,4-Disulfonyl phenyl butyl nitrone its salts and their use as pharmaceuticals